News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC
Yüksel Ürün/X
Feb 18, 2025, 15:11

Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:

“Denosumab every 12 weeks vs. every 4 weeks in mCRPC:

Lower risk of ONJ and tooth infections with q12w dosing.

Favorable long-term safety profile.

Could q12w become the new standard?”

Yüksel Ürün: Denosumab every 12 weeks vs. every 4 weeks in mCRPC

More posts featuring Yüksel Ürün.

cancer denosumab mCRPC OncoDaily Oncology Yüksel Ürün
Special Coverage
Opinion
Aug 8, 2025, 21:29
Ilyas Sahin: Two Important Cancer Studies
Blog
Aug 8, 2025, 21:08
What’s Now and What’s Next - NFCR
Insight
Aug 8, 2025, 20:54
Yan Leyfman: AI in Oncology Just Leveled Up
Blog
Aug 8, 2025, 20:48
The NCI CPFP Application Period Closes Next Month - NCI Division of Cancer Prevention
Blog
Aug 8, 2025, 20:41
Tackling Cancer Misinformation with Expert Stacy Loeb - Conquer Cancer, the ASCO Foundation
Blog
Aug 8, 2025, 20:37
Every Day Matters When It Comes to Lung Cancer Awareness - Oncogene Cancer Research
Blog
Aug 8, 2025, 20:32
Registrations Are Open for the European Cancer Summit - European Cancer Organisation
Blog
Aug 8, 2025, 20:18
Childhood Cancer International Raises €4,500
Blog
Aug 8, 2025, 20:03
Turning Commitment into Action, and Action into Impact - CANCaRe Africa
Blog
Aug 8, 2025, 19:51
The Countdown Is On for Ambassadors' Annual Gala Dinner - World Child Cancer
Blog
Aug 8, 2025, 19:34
What are the Latest Policy Updates for the Lung Cancer Community?
Insight
Aug 8, 2025, 19:27
"Lineage Switch" in Acute Leukemia After Targeted Immunotherapy - NCI Center for Cancer Research